Cartilage tissue formation from dedifferentiated chondrocytes by codelivery of BMP-2 and SOX-9 genes encoding bicistronic vector

Cell Transplantation

Volumn 22, Issue 9, 2013, Pages 1519-1528

  Cha, Byung Hyun ^a   Kim, Jae Hwan ^a   Kang, Sun Woong ^a   Do, Hyun Jin ^a   Jang, Ju Woong ^b   Choi, Yon Rak ^b   Park, Hansoo ^c   Kim, Byung Soo ^d   Lee, Soo Hong ^a  

^a CHA University   (South Korea)

^b Acetechno Tower IX   (South Korea)

^c Chung Ang University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Bone morphogenetic protein 2 (BMP 2); Cartilage tissue formation; Codelivery; Dedifferentiation; Sex determining region Y box gene 9 (SOX 9)

Indexed keywords

AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 2; TRANSCRIPTION FACTOR SOX9;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL STRUCTURE; CHONDROGENESIS; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CARTILAGE, ARTICULAR; CELL DEDIFFERENTIATION; CHONDROCYTES; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; SOX9 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84883532271     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X647261     Document Type: Article

References (39)

1. Bi, W.; Deng, J. M.; Zhang, Z.; Behringer, R. R.; de Crombrugghe, B. Sox9 is required for cartilage formation. Nat. Genet. 22(l):85-89; 1999.
2. Blaney Davidson, E. N.; Vitters, E. L.; van Lent, P. L.; van de Loo, F. A.; van den Berg, W. B.; van der Kraan, P. M. Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling. Arthritis Res. Then 9(5):R102; 2007.
3. Brittberg, M.; Lindahl, A.; Nilsson, A.; Ohlsson, C; Isaksson, O.; Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331(14):889-895; 1994.
4. Cao, L.; Yang, E; Liu, G.; Yu, D.; Li, H.; Fan, Q.; Gan, Y; Tang, T.; Dai, K. The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials 32(16):3910-3920; 2011.
5. DeLise, A. M.; Fischer, L.; Tuan, R. S. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 8(5):309-334; 2000.
6. Duprez, D. M.; Coltey, M.; Amthor, H.; Brickell, P. M.; Tickle, C. Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures. Dev. Biol. 174(2):448-452; 1996.
7. Enomoto-Iwamoto, M.; Iwamoto, M.; Mukudai, Y; Kawakami, Y; Nohno, T.; Higuchi, Y; Takemoto, S.; Ohuchi, H.; Noji, S.; Kurisu, K. Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes. J. Cell Biol. 140(2):409-418; 1998.
8. Gaissmaier, C; Koh, J. L.; Weise, K.; Mollenhauer, J. A. Future perspectives of articular cartilage repair. Injury 39(Suppl. 1):S114-S120; 2008.
9. Guilak, E; Lott, K. E.; Awad, H. A.; Cao, Q.; Hicok, K. C; Fermor, B.; Gimble, J. M. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J. Cell. Physiol. 206(l):229-237; 2006.
10. Jiang, Y Z.; Zhang, S. E; Qi, Y Y.; Wang, L. L.; Ouyang, H. W. Cell transplantation for articular cartilage defects: Principles of past, present and future practice. Cell Transplant. 20(5):593-607; 2011.
11. Kang, S. W.; Kim, J. S.; Park, K. S.; Cha, B. PL; Shim, J. PL; Kim, J. Y; Cho, D. W.; Rhie, J. W.; Lee, S. H. Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. Bone 48(2):298-306; 2011.
12. Kim, Y H.; Lee, J. W. Targeting of focal adhesion kinase by small interfering RNAs reduces chondrocyte redifferentia-tion capacity in alginate beads culture with type II collagen. J. Cell. Physiol. 218(3):623-630; 2009.
13. Kupcsik, L.; Stoddart, M. J.; Li, Z.; Benneker, L. M.; Alini, M. Improving chondrogenesis: Potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. Tissue Eng. Part A 16(6): 1845-1855; 2010.
14. Lee, D. K; Choi, K B.; Oh, I. S.; Song, S. U.; Hwang, S.; Lim, C. L.; Hyun, J. P.; Lee, H. Y; Chi, G. E; Yi, Y; Yip, V.; Kim, J.; Lee, E. B.; Noh, M. J.; Lee, K. H. Continuous transforming growth factor β1 secretion by cell-mediated gene therapy maintains chondrocyte redifferentiation. Tissue Eng. 11(1-2):310-318; 2005.
15. Lee, S. J.; Kang, S. W.; Do, H. J.; Han, I.; Shin, D. A.; Kim, J. H.; Lee, S. H. Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells. Biomaterials 31(21):5652-5659; 2010.
16. Lefebvre, V.; Huang, W.; Harley, V. R.; Goodfellow, P. N.; de Crombrugghe, B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro α1(II) collagen gene. Mol. Cell. Biol. 17(4):2336-2346; 1997.
17. Lefebvre, V.; Peeters-Joris, C; Vaes, G. Production of col-lagens, collagenase and collagenase inhibitor during the dedifferentiation of articular chondrocytes by serial subcultures. Biochim. Biophys. Acta 1051(3):266-275; 1990.
18. Malda, J.; van Blitterswijk, C. A.; van Geffen, M.; Martens, D. E.; Tramper, J.; Riesle, J. Low oxygen tension stimulates the redifferentiation of dedifferentiated adult human nasal chondrocytes. Osteoarthritis Cartilage 12(4):306-313; 2004.
19. Marijnissen, A. C; Lafeber, E P. Re: E. B. Hunziker. Articular cartilage repair: Basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage 2002; 10:432-63. Osteoarthritis Cartilage 11(4):300-301; author reply 302-304; 2003.
20. Markway, B. D.; Tan, G. K; Brooke, G; Hudson, J. E.; Cooper-White, J. J.; Doran, M. R. Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant. 19(1):29-32; 2010.
21. Martin, I.; Vunjak-Novakovic, G; Yang, J.; Langer, R.; Freed, L. E. Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp. Cell Res. 253(2):681-688; 1999.
22. Martinez, I.; Elvenes, J.; Olsen, R.; Bertheussen, K; Johansen, O. Redifferentiation of in vitro expanded adult articular chondrocytes by combining the hanging-drop cultivation method with hypoxic environment. Cell Transplant. 17(8):987-996; 2008.
23. Pan, Q.; Yu, Y; Chen, Q.; Li, C; Wu, H.; Wan, Y; Ma, L; Sun, E Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. J. Cell. Physiol. 217(1):228-241; 2008.
24. Prakash, D.; Learmonth, D. Natural progression of osteo-chondral defect in the femoral condyle. Knee 9(1):7-10; 2002.
25. Ryan, M. D.; Drew, J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBOJ. 13(4):928-933; 1994.
26. Ryan, M. D.; King, A. M.; Thomas, G. P. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 72 (Pt ll):2727-2732; 1991.
27. Sailor, L. Z.; Hewick, R. M.; Morris, E. A. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J. Orthop. Res. 14(6):937-945; 1996.
28. Salentey, V.; Claus, S.; Bougault, C; Paumier, A.; Aubert-Foucher, E.; Perrier-Groult, E.; Ronziere, M. C; Freyria, A. M.; Galera, P.; Beauchef, G; Duterque-Coquillaud, M.; Piperno, M.; Damour, O.; Herbage, B.; Mallein-Gerin, F. Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: Potential use of bone morphogenetic protein-2 for cartilage cell therapy. Pathol. Biol. 57(4):282-289; 2009.
29. Tew, S. R.; Hardingham, T. E. Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J. Biol. Chem. 281(51):39471-39479; 2006.
30. Van Susante, J. L.; Buma, P.; van Beuningen, H. M.; van den Berg, W. B.; Veth, R. P. Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations. J. Orthop. Res. 18(l):68-77; 2000.
31. Wang, Y. H.; Ho, M. L.; Chang, J. K.; Chu, H. C; Lai, S. C; Wang, G. J. Microporation is a valuable transfec-tion method for gene expression in human adipose tissue-derived stem cells. Mol. Then 17(2):302-308; 2009.
32. Weiser, L.; Bhargava, M.; Attia, E.; Torzilli, P. A. Effect of serum and platelet-derived growth factor on chondrocytes grown in collagen gels. Tissue Eng. 5(6):533-544; 1999.
33. Wu, W. T.; Lyu, S. R.; Hsieh, W. H. Cryopreservation and biophysical properties of articular cartilage chondrocytes. Cryobiology 51(3):330-338; 2005.
34. Xian, C. J.; Foster, B. K. Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy. Curr. Stem Cell Res. Ther. 1(2): 213-229; 2006.
35. Yang, K. G.; Saris, D. B.; Geuze, R. E.; Helm, Y J.; Rijen, M. H.; Verbout, A. J.; Dhert, W. J.; Creemers, L. B. Impact of expansion and redifferentiation conditions on chondrogenic capacity of cultured chondrocytes. Tissue Eng. 12(9): 2435-2447; 2006.
36. Zehentner, B. K.; Dony, C; Burtscher, H. The transcription factor Sox9 is involved in BMP-2 signaling. J. Bone Miner. Res. 14(10):1734-1741; 1999.
37. Zhao, Q.; Eberspaecher, H.; Lefebvre, V; De Crombrugghe, B. Parallel expression of Sox9 and Col2al in cells undergoing chondrogenesis. Dev. Dyn. 209(4):377-386; 1997.
38. Zuk, P. A.; Zhu, M.; Ashjian, P.; De Ugarte, D. A.; Huang, J. I.; Mizuno, H.; Alfonso, Z. C; Fraser, J. K.; Benhaim, P.; Hedrick, M. H. Human adipose tissue is a source of multipo-tent stem cells. Mol. Biol. Cell 13(12):4279-4295; 2002.
39. Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7(2):211-228; 2001.